FOR 50 YEARS THE CIA HID RESEARCH REGARDING DRUGS LIKE IVERMECTIN AND CANCER

by The Wellness Company

According to The Daily Mail, a declassified CIA document is raising concerns that the agency purposely suppressed information that could have been a valuable tool in treating cancer:

A newly surfaced CIA document suggests US intelligence once reviewed research that hinted at a possible cancer treatment more than 60 years ago. 

The document, produced in February 1951 and declassified in 2014, summarizes a Soviet scientific paper that examined striking similarities between parasitic worms and cancerous tumors. 

The report describes how researchers believed both organisms thrived under nearly identical metabolic conditions and accumulated large reserves of glycogen, a form of stored energy. 

Indeed, Soviet research regarding anti-parasticis and cancer at the time was showing promising results:

The research also highlighted experiments showing that certain chemical compounds were capable of targeting both parasitic infections and malignant tumors. 

One drug, Myracyl D, was reportedly effective against bilharzia parasites as well as cancerous growths, hinting that treatments developed for parasites might also attack tumors. 

According to Nicolas Hulscher with The McCullough Foundation, “Instead of being used to advance critical cancer research, the document was buried for over half a century.”

Recent Data Also Ignored

It’s not just the results of these Soviet studies that were buried for decades by the CIA. The off-label use of of anti-parasitic drugs like ivermectin and mebendazole have demonstrated highly promising anti-cancer activity in preclinical models. But despite compelling preclinical data and documented safe use in cancer patients, robust clinical evidence evaluating the ivermectin–mebendazole combination in oncology remains limited.

This is Why The Wellness Company Conducted its own Study

Treating cancer is big business and one that makes the big pharmaceutical companies massive amounts of cash. In 2024 alone, cancer treatments generated at least $200 billion in worldwide sales for the pharmaceutical industry.

Given the massive profit motive it shouldn’t be surprising that big pharma has shown zero interest in low-cost cancer treatments.

This is exactly why Dr. Peter McCullough, and a number of his colleagues at The Wellness Company, have recently authored a first of its kind study of the application of Ivermectin+Mebendazole in the treatment of cancer.

The results of this study are nothing short of groundbreaking.

84% Clinical Benefit 

In a first-of-its-kind report, 197 cancer patients were prescribed The Wellness Company’s compounded Ivermectin (25mg) + Mebendazole (250mg). Of the 122 patients who completed the 6-month follow-up:

  • 84.4% reported clinical benefit (no evidence of disease, tumor shrinkage, or stable disease)
  • 48.4% reported the strongest positive outcomes — tumor shrinkage or no current evidence of disease
  • 86.9% completed their initial prescription with most side effects reported as mild

These two Nobel Prize-recognized and FDA-approved compounds work through a dual-action mechanism: Ivermectin disrupts tumor growth pathways and triggers cancer cell death (apoptosis), while Mebendazole starves abnormal cells by blocking their ability to absorb glucose. Together, in one compounded capsule, they deliver a protocol that patients could actually follow — and did.

According to Dr. McCullough, “This study reveals an exciting new potential that should expand the consideration of ivermectin and mebendazole for inclusion in the treatment of multiple cancer types. We urgently need a full-fledged scientific investigation into this class of medications and their impact on cancer treatment.”

What Does this Potential Breakthrough mean for You?

Here is a tough reality – Cancer doesn’t care how healthy you are. It doesn’t announce itself. And by the time most people find out, they’re handed a treatment plan that’s brutal on the body, devastating on the wallet, and uncertain in its results. Standard chemotherapy drugs can cost tens of thousands of dollars per cycle — and too often, the outcomes don’t match the price tag.

And here’s what makes it worse: you feel powerless. You’re told there’s only one path — the conventional path — and questioning it makes you a “difficult person.”
Meanwhile, you watch the side effects pile up, the bills multiply, and the uncertainty eat away at your peace of mind. You’re left wondering: Is this really the best we can do?

We need effective options that work with the body — not against it — that are accessible, affordable, and backed by real clinical data.

Every day without a proactive plan is another day you’re leaving your health to chance. Cancer rates are rising, and conventional treatments alone aren’t delivering the results patients deserve. But now, there’s real-world clinical evidence pointing to a powerful complementary option — compounded by a licensed 50-state U.S. pharmacy and prescribed by licensed American doctors.

If you or someone you love is facing a cancer diagnosis — or if you simply believe in taking a proactive approach to your health — then getting The Wellness Company’s Ivermectin + Mebendazole into your hands is the right decision.

Have a clinically studied, doctor-prescribed tool in your corner — one that’s affordable, easy to follow, and backed by the kind of real-world results that give you and your family genuine hope and control over your health.

full story at https://www.zerohedge.com/sponsored-post/50-years-cia-hid-research-regarding-drugs-ivermectin-and-cancer

Tags: , , , , , , , , , ,